JOHN DEMAREE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN DEMAREE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN DEMAREE. JOHN DEMAREE is a Chief Commercial Officer in Karyopharm Therapeutics Inc. ($KPTI) and a Chief Commercial Officer in G1 Therapeutics, Inc. ($GTHX).
Address: C/O G1 THERAPEUTICS, 79 TW ALEXANDER DR. 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK 27709 NC
Companies in which JOHN DEMAREE is an Insider
G1 Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN DEMAREE: Chief Commercial Officer
Holdings: 5,250 shares
Latest Transaction: Jan 02 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Karyopharm Therapeutics Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN DEMAREE: Chief Commercial Officer
Holdings: 23,995 shares
Current Value: $247,628
Latest Transaction: Mar 01 2021
$KPTI Market Capitalization: $416.55M
$KPTI Previous Close: $10.32
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of JOHN DEMAREE
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 01 2021 | KPTI | Karyopharm Therape ... | DEMAREE JOHN | Chief Commercial Of ... | Option Exercise | A | 14.56 | 43,177 | 628,657 | 43,177 | |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | DEMAREE JOHN | Chief Commercial Of ... | Grant | A | 0.00 | 15,849 | 0 | 23,995 | 8.1 K to 24 K (+194.56 %) |
| Mar 17 2020 | KPTI | Karyopharm Therape ... | DEMAREE JOHN | Chief Commercial Of ... | Option Exercise | A | 16.50 | 151,200 | 2,494,800 | 151,200 | |
| Jan 02 2019 | GTHX | G1 Therapeutics, I ... | DEMAREE JOHN | Chief Commercial Of ... | Option Exercise | A | 19.56 | 60,000 | 1,173,600 | 60,000 | |
| Dec 11 2018 | GTHX | G1 Therapeutics, I ... | DEMAREE JOHN | Chief Commercial Of ... | Buy | P | 33.15 | 1,000 | 33,151 | 5,250 | 4.3 K to 5.3 K (+23.53 %) |
| Jul 06 2018 | GTHX | G1 Therapeutics, I ... | DEMAREE JOHN | Chief Commercial Of ... | Option Exercise | A | 45.50 | 225,000 | 10,237,500 | 225,000 |